Business Description
Ebos Group Ltd
ISIN : NZEBOE0001S6
Share Class Description:
EBOSF: Ordinary SharesCompare
Compare
Traded in other countries / regions
EBO.New ZealandEBO.AustraliaEJG.GermanyEBOSF.USA IPO Date
2014-08-13Description
Ebos is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.13 | |||||
| Equity-to-Asset | 0.36 | |||||
| Debt-to-Equity | 0.67 | |||||
| Debt-to-EBITDA | 2.76 | |||||
| Interest Coverage | 5.79 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 3.2 | |||||
| Beneish M-Score | -2.47 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7.5 | |||||
| 3-Year EBITDA Growth Rate | 13.1 | |||||
| 3-Year EPS without NRI Growth Rate | 7.2 | |||||
| 3-Year FCF Growth Rate | 1.9 | |||||
| 3-Year Book Growth Rate | 14.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 8.17 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.95 | |||||
| Quick Ratio | 0.57 | |||||
| Cash Ratio | 0.07 | |||||
| Days Inventory | 39.53 | |||||
| Days Sales Outstanding | 39.82 | |||||
| Days Payable | 67.14 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Dividend Growth Rate | 11.4 | |||||
| 3-Year Average Share Buyback Ratio | -5.6 | |||||
| Shareholder Yield % | -3.02 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 12.38 | |||||
| Operating Margin % | 3.66 | |||||
| Net Margin % | 2.06 | |||||
| FCF Margin % | 1.99 | |||||
| ROE % | 11.3 | |||||
| ROA % | 4.08 | |||||
| ROIC % | 8.1 | |||||
| ROC (Joel Greenblatt) % | 43.88 | |||||
| ROCE % | 12.06 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 24.45 | |||||
| Forward PE Ratio | 29.64 | |||||
| PE Ratio without NRI | 24.28 | |||||
| Shiller PE Ratio | 29.95 | |||||
| Price-to-Owner-Earnings | 18.7 | |||||
| PEG Ratio | 1.71 | |||||
| PS Ratio | 0.5 | |||||
| PB Ratio | 2.72 | |||||
| Price-to-Free-Cash-Flow | 25.2 | |||||
| Price-to-Operating-Cash-Flow | 19.08 | |||||
| EV-to-EBIT | 17.48 | |||||
| EV-to-Forward-EBIT | 15.93 | |||||
| EV-to-EBITDA | 13.69 | |||||
| EV-to-Forward-EBITDA | 13.24 | |||||
| EV-to-Revenue | 0.62 | |||||
| EV-to-Forward-Revenue | 0.65 | |||||
| EV-to-FCF | 30.91 | |||||
| Price-to-Projected-FCF | 1.51 | |||||
| Price-to-DCF (Earnings Based) | 2 | |||||
| Price-to-DCF (FCF Based) | 2.1 | |||||
| Price-to-Median-PS-Value | 1.13 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.72 | |||||
| Earnings Yield (Greenblatt) % | 5.72 | |||||
| FCF Yield % | 3.92 | |||||
| Forward Rate of Return (Yacktman) % | 17.52 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:EBOSF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ebos Group Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 8,906.17 | ||
| EPS (TTM) ($) | 0.954 | ||
| Beta | 0.11 | ||
| Volatility % | 1.75 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 28.25 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 28.25 - 28.25 | ||
| Shares Outstanding (Mil) | 194.68 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ebos Group Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ebos Group Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Ebos Group Ltd Frequently Asked Questions
What is Ebos Group Ltd(EBOSF)'s stock price today?
The current price of EBOSF is $28.25. The 52 week high of EBOSF is $28.25 and 52 week low is $28.25.
When is next earnings date of Ebos Group Ltd(EBOSF)?
The next earnings date of Ebos Group Ltd(EBOSF) is 2025-02-21 Est..
Does Ebos Group Ltd(EBOSF) pay dividends? If so, how much?
Ebos Group Ltd(EBOSF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers